Novo Nordisk (NVO) announced Saturday that its pending acquisition of three Catalent (NYSE:CTLT) production sites is expected ...

Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a ...

A new study confirms a link between Novo Nordisk's Ozempic and an increased risk of NAION, a rare, irreversible form of ...

Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a ...

Novo Holdings will proceed with its $16.5 billion acquisition of Catalent, the companies announced Saturday, after the ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...

Americans pay more for health care but don't get better results. Why? The blame goes well beyond insurance companies.

The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a ...

Ukrainian President Volodymyr Zelenskiy says he has instructed his government to set up supply mechanisms to deliver together ...

It's been six months since I accidentally poisoned myself with a weight-loss jab I shouldn't have taken. But while the memory ...

Sarcopenic obesity, a dangerous combination of muscle loss and weight gain, is increasingly affecting younger South Africans.